N4-hydroxycytidine, the active compound of Molnupiravir, promotes SARS-CoV-2 mutagenesis and escape from a neutralizing nanobody
Summary: N4-hydroxycytidine (NHC), the active compound of the drug Molnupiravir, is incorporated into SARS-CoV-2 RNA, causing false base pairing. The desired result is an “error catastrophe,” but this bears the risk of mutated virus progeny. To address this experimentally, we propagated the initial...
প্রধান লেখক: | , , , , , , , , , , , , |
---|---|
বিন্যাস: | প্রবন্ধ |
ভাষা: | English |
প্রকাশিত: |
Elsevier
2023-10-01
|
মালা: | iScience |
বিষয়গুলি: | |
অনলাইন ব্যবহার করুন: | http://www.sciencedirect.com/science/article/pii/S2589004223018631 |